CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.17
-0.16 (-2.91%)
At close: Jul 10, 2026, 4:00 PM EDT
5.27
+0.10 (2.03%)
After-hours: Jul 10, 2026, 4:58 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $7.55 million as of July 10, 2026. Its market cap has increased by 72.75% in one year.
Market Cap
7.55M
Enterprise Value
4.83M
1-Year Change
72.75%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $7.55M, a decrease of -89.20%. That is a compound annual growth rate of -28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.55M | 131.79% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 8.49M |
| TransCode Therapeutics | 8.39M |
| Cadrenal Therapeutics | 8.29M |
| Jupiter Neurosciences | 8.25M |
| Aspire Biopharma Holdings | 7.78M |
| Kairos Pharma | 7.55M |
| PharmaCyte Biotech | 7.48M |
| Bolt Biotherapeutics | 7.26M |